EPB41L4B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.077400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.672000E-01
Normal-vs-Stage2
5.184200E-01
Normal-vs-Stage3
6.264600E-01
Normal-vs-Stage4
6.775600E-01
Stage1-vs-Stage2
8.720600E-01
Stage1-vs-Stage3
8.348000E-01
Stage1-vs-Stage4
9.304000E-01
Stage2-vs-Stage3
9.494400E-01
Stage2-vs-Stage4
9.616200E-01
Stage3-vs-Stage4
9.375000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.206800E-01
Normal-vs-AfricanAmerican
1.419020E-01
Normal-vs-Asian
5.823200E-01
Caucasian-vs-AfricanAmerican
2.922600E-01
Caucasian-vs-Asian
8.330400E-01
AfricanAmerican-vs-Asian
2.051600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.661800E-01
Normal-vs-Female
5.646000E-01
Male-vs-Female
8.898600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.075000E-01
Normal-vs-Age(41-60Yrs)
5.179600E-01
Normal-vs-Age(61-80Yrs)
4.740000E-01
Normal-vs-Age(81-100Yrs)
9.920200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.354400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.592100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.825600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.538000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.348600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.697610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.052400E-01
Normal-vs-Daily Drinker
5.297800E-01
Normal-vs-Weekly Drinker
8.259400E-01
Normal-vs-Occasional Drinker
5.372800E-01
Normal-vs-Social Drinker
6.241200E-01
Non Drinker-vs-Daily Drinker
5.530800E-01
Non Drinker-vs-Weekly Drinker
2.090400E-01
Non Drinker-vs-Occasional Drinker
7.121800E-01
Non Drinker-vs-Social Drinker
6.576400E-01
Daily Drinker-vs-Weekly Drinker
4.346600E-01
Daily Drinker-vs-Occasional Drinker
4.815800E-01
Daily Drinker-vs-Social Drinker
9.750800E-01
Weekly Drinker-vs-Occasional Drinker
2.502600E-01
Weekly Drinker-vs-Social Drinker
5.242200E-01
Occasional Drinker-vs-Social Drinker
5.556200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.908000E-01
Normal-vs-Grade 2
4.772800E-01
Normal-vs-Grade 3
4.663200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.277990E-02
Grade 1-vs-Grade 3
1.193550E-02
Grade 1-vs-Grade 4
2.908000E-01
Grade 2-vs-Grade 3
8.624400E-01
Grade 2-vs-Grade 4
4.772800E-01
Grade 3-vs-Grade 4
4.663200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.794400E-01
Normal-vs-NonDiabetic
5.192400E-01
Diabetic-vs-NonDiabetic
3.109200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.940600E-01
Normal-vs-NoPancreatitis
5.232000E-01
Pancreatitis-vs-NoPancreatitis
1.264240E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.778200E-01
Normal-vs-N1
5.339000E-01
N0-vs-N1
2.429000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.417600E-01
Normal-vs-TP53-NonMutant
2.362200E-01
TP53-Mutant-vs-TP53-NonMutant
2.183200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
